{"id":7074,"date":"2024-06-18T10:19:47","date_gmt":"2024-06-18T02:19:47","guid":{"rendered":"https:\/\/chimebiologics.com\/?p=7074"},"modified":"2025-06-12T13:56:43","modified_gmt":"2025-06-12T05:56:43","slug":"going-global-chime-biologics-embraces-innovation-and-quality-with-partners","status":"publish","type":"post","link":"https:\/\/chimebiologics.com\/ja\/going-global-chime-biologics-embraces-innovation-and-quality-with-partners\/","title":{"rendered":"(English) Going Global - Chime Biologics Embraces Innovation and Quality with Partners"},"content":{"rendered":"<p class=\"qtranxs-available-languages-message qtranxs-available-languages-message-ja\">\u7533\u3057\u8a33\u3042\u308a\u307e\u305b\u3093\u3001\u3053\u306e\u30b3\u30f3\u30c6\u30f3\u30c4\u306f\u305f\u3060\u4eca\u3000<a href=\"https:\/\/chimebiologics.com\/en\/wp-json\/wp\/v2\/posts\/7074\" class=\"qtranxs-available-language-link qtranxs-available-language-link-en\" title=\"English\">English<\/a>\u3068 <a href=\"https:\/\/chimebiologics.com\/zh\/wp-json\/wp\/v2\/posts\/7074\" class=\"qtranxs-available-language-link qtranxs-available-language-link-zh\" title=\"\u4e2d\u6587\">\u4e2d\u6587<\/a>\u3000\u306e\u307f\u3067\u3059\u3002 For the sake of viewer convenience, the content is shown below in this site default language. You may click one of the links to switch the site language to another available language.<\/p><style type=\"text\/css\" data-created_by=\"avia_inline_auto\" id=\"style-css-av-iwqe2-97bb6aa3783a5420eb8a707e0ad897c8\">\n.flex_column.av-iwqe2-97bb6aa3783a5420eb8a707e0ad897c8{\n-webkit-border-radius:0px 0px 0px 0px;\n-moz-border-radius:0px 0px 0px 0px;\nborder-radius:0px 0px 0px 0px;\npadding:0px 0px 0px 0px;\n}\n<\/style>\n<div class='flex_column av-iwqe2-97bb6aa3783a5420eb8a707e0ad897c8 av_two_third  avia-builder-el-0  el_before_av_one_third  avia-builder-el-first  first flex_column_div av-zero-column-padding '     ><section  class='av_textblock_section av-k6j2pxor-09272cddfdcc1afe6211303b3b3d55e0'  itemscope=\"itemscope\" itemtype=\"https:\/\/schema.org\/BlogPosting\" itemprop=\"blogPost\" ><div class='avia_textblock'  itemprop=\"text\" ><p><\/p>\n<\/div><\/section><\/div>\n<style type=\"text\/css\" data-created_by=\"avia_inline_auto\" id=\"style-css-av-2d3l4o-9301d0cdc14489efa114080353995aa9\">\n.flex_column.av-2d3l4o-9301d0cdc14489efa114080353995aa9{\n-webkit-border-radius:0px 0px 0px 0px;\n-moz-border-radius:0px 0px 0px 0px;\nborder-radius:0px 0px 0px 0px;\npadding:0px 0px 0px 0px;\n}\n<\/style>\n<div class='flex_column av-2d3l4o-9301d0cdc14489efa114080353995aa9 av_one_third  avia-builder-el-2  el_after_av_two_third  el_before_av_one_full  flex_column_div av-zero-column-padding '     ><\/div><\/p>\n<div class='flex_column av-av_one_full-7714eba142aeda1f8b5272a3c372b279 av_one_full  avia-builder-el-3  el_after_av_one_third  avia-builder-el-last  first flex_column_div column-top-margin'     ><section  class='av_textblock_section av-mbsytcb3-888c1e21ea57c735b144f6e15e4133f4'  itemscope=\"itemscope\" itemtype=\"https:\/\/schema.org\/BlogPosting\" itemprop=\"blogPost\" ><div class='avia_textblock'  itemprop=\"text\" ><p><\/p>\n<h1><strong>Going Global-Chime Biologics Embraces Innovation and Quality with Partners<\/strong><\/h1>\n<ul>\n<li><b><i><\/i><\/b><strong><em><b><i>Foreign biopharmaceutical companies seek CDMO partners with long-term prospects, technology levels, and quality systems aligned with international standards<\/i><\/b><\/em><\/strong><strong><em><b><i>.<\/i><\/b><\/em><\/strong><\/li>\n<li><b><i><\/i><\/b><strong><em><b><i> Jimmy Wei, President of Chime Biologics, highlighted that the company's competitive edge arises from ensuring product quality, leveraging efficiencies, and maintaining stringent cost controls<\/i><\/b><\/em><\/strong><strong><em><b><i>.<\/i><\/b><\/em><\/strong><strong><em><b><i><img loading=\"lazy\" decoding=\"async\" class=\"aligncenter wp-image-7071 size-full\" src=\"https:\/\/chimebiologics.com\/wp-content\/uploads\/2024\/06\/0705-\u9f0e\u5eb7\u82f1\u6587\u7248\u914d\u56fe1.png\" alt=\"\" width=\"1227\" height=\"818\" srcset=\"https:\/\/chimebiologics.com\/wp-content\/uploads\/2024\/06\/0705-\u9f0e\u5eb7\u82f1\u6587\u7248\u914d\u56fe1.png 1227w, https:\/\/chimebiologics.com\/wp-content\/uploads\/2024\/06\/0705-\u9f0e\u5eb7\u82f1\u6587\u7248\u914d\u56fe1-300x200.png 300w, https:\/\/chimebiologics.com\/wp-content\/uploads\/2024\/06\/0705-\u9f0e\u5eb7\u82f1\u6587\u7248\u914d\u56fe1-1030x687.png 1030w, https:\/\/chimebiologics.com\/wp-content\/uploads\/2024\/06\/0705-\u9f0e\u5eb7\u82f1\u6587\u7248\u914d\u56fe1-768x512.png 768w, https:\/\/chimebiologics.com\/wp-content\/uploads\/2024\/06\/0705-\u9f0e\u5eb7\u82f1\u6587\u7248\u914d\u56fe1-705x470.png 705w\" sizes=\"auto, (max-width: 1227px) 100vw, 1227px\" \/><\/i><\/b><\/em><\/strong><\/li>\n<\/ul>\n<p><strong><b>July <\/b><\/strong><strong><b>5<\/b><\/strong><strong><b>, 2024, Shanghai<\/b><\/strong><strong><b>, China<\/b><\/strong> \u2013 Chime Biologics, a leading global CDMO that enables its partners' success in biologics, affirmed its commitment to innovation and quality at the recent China Biologics Going Global Forum held in Shanghai.<\/p>\n<p>Dr. Jimmy Wei, President of Chime Biologics, highlighted that the company's competitive edge arises from ensuring product quality, leveraging efficiencies, and maintaining stringent cost controls. Chime Biologics' lead investor, VMS Group, also attended this forum. Andrew Ng, Partner and Head of Healthcare of VMS Group, shared that since 2017, about 70% of VMS healthcare investments have been in the Greater China region, with the remainder invested in the global market, especially in Europe and the United States.<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-full wp-image-7072\" src=\"https:\/\/chimebiologics.com\/wp-content\/uploads\/2024\/06\/0705-\u9f0e\u5eb7\u82f1\u6587\u7248\u6587\u7ae0\u914d\u56fe.png\" alt=\"\" width=\"1201\" height=\"800\" srcset=\"https:\/\/chimebiologics.com\/wp-content\/uploads\/2024\/06\/0705-\u9f0e\u5eb7\u82f1\u6587\u7248\u6587\u7ae0\u914d\u56fe.png 1201w, https:\/\/chimebiologics.com\/wp-content\/uploads\/2024\/06\/0705-\u9f0e\u5eb7\u82f1\u6587\u7248\u6587\u7ae0\u914d\u56fe-300x200.png 300w, https:\/\/chimebiologics.com\/wp-content\/uploads\/2024\/06\/0705-\u9f0e\u5eb7\u82f1\u6587\u7248\u6587\u7ae0\u914d\u56fe-1030x686.png 1030w, https:\/\/chimebiologics.com\/wp-content\/uploads\/2024\/06\/0705-\u9f0e\u5eb7\u82f1\u6587\u7248\u6587\u7ae0\u914d\u56fe-768x512.png 768w, https:\/\/chimebiologics.com\/wp-content\/uploads\/2024\/06\/0705-\u9f0e\u5eb7\u82f1\u6587\u7248\u6587\u7ae0\u914d\u56fe-705x470.png 705w\" sizes=\"auto, (max-width: 1201px) 100vw, 1201px\" \/><\/p>\n<p style=\"text-align: center;\"><span style=\"color: #999999;\">Dr. Jimmy Wei, President\u00a0of Chime Biologics<\/span><\/p>\n<div class=\"mceTemp\"><\/div>\n<p>Bing Chen, Vice President of International BD and Venture Fund at AstraZeneca mentioned that it was previously sufficient for innovative medicines to be a regional leader, but winning products now need to be best-in-class globally. By launching best-in-class products, Chinese pharmaceutical companies are more likely to attract additional global collaboration opportunities.<\/p>\n<p><strong><b>Speeding Up Globalization<\/b><\/strong><\/p>\n<p>In a roundtable discussion moderated by Dr. Hongtao\u00a0Lu, co-founder and Chief Scientist of Elpiscience, a panel of industry leaders noted that though local pharmaceuticals have created many clinically valuable products such as bispecific antibodies that are typically used for cancer treatment, there are relatively few products that leaped from zero to one.<\/p>\n<p>Global CDMOs such as Chime Biologics\u00a0play an important role in global innovation, with a significant increase in licensing deals between local biotech companies and U.S.\/European biopharmaceutical companies, especially in license-out deals. Chime Biologics can help biotech companies go to market from the pre-clinical to commercial manufacturing stages, leading to a win-win situation, which will be a major trend in the next decade.<\/p>\n<p><strong><b>Charting a Sustainable Growth Trajectory<\/b><\/strong><\/p>\n<p>Dr. Jimmy Wei, President of Chime Biologics, observed that: \"Foreign biopharmaceutical companies have gone through several market cycles, and when they choose CDMOs, they are more concerned about its long-term developmental prospects, the technology level, and whether the quality systems are aligned with international standards. Domestic companies also have higher requirements when looking for partners now.\"<\/p>\n<p>With a focus on innovation and quality, the Chinese biopharmaceutical industry is actively charting a sustainable growth trajectory internationally, which was often echoed by speakers and panelists at this forum when discussing drivers to enhance the industry's global presence and competitiveness in international markets.<\/p>\n<p><strong><b>About Chime Biologics<\/b><\/strong><\/p>\n<p>Chime Biologics is a global leading global CDMO with the world's first modular biopharmaceutical factory, KUBio. It empowers the entire biologics processes - from cell line development to commercial manufacturing. Chime Biologics provides one-stop CMC solutions to worldwide biomedical customers, relying on cell line development and advanced technology development from its Innovation Center in Shanghai and proven success in IND-enabling through BLA filing at its Wuhan campus. We share a common goal to make cutting-edge biologics affordable and accessible to all patients globally, fulfilling its commitment to human health.\u00a0 For more information, please visit <a href=\"http:\/\/www.chimebiologics.com\/\"><u>www.chimebiologics.com<\/u><\/a>.<\/p>\n<p><\/p>\n<\/div><\/section><\/div>","protected":false},"excerpt":{"rendered":"","protected":false},"author":2,"featured_media":7076,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[46,52],"tags":[],"class_list":["post-7074","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-corporate-news","category-news"],"_links":{"self":[{"href":"https:\/\/chimebiologics.com\/ja\/wp-json\/wp\/v2\/posts\/7074","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/chimebiologics.com\/ja\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/chimebiologics.com\/ja\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/chimebiologics.com\/ja\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/chimebiologics.com\/ja\/wp-json\/wp\/v2\/comments?post=7074"}],"version-history":[{"count":14,"href":"https:\/\/chimebiologics.com\/ja\/wp-json\/wp\/v2\/posts\/7074\/revisions"}],"predecessor-version":[{"id":8715,"href":"https:\/\/chimebiologics.com\/ja\/wp-json\/wp\/v2\/posts\/7074\/revisions\/8715"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/chimebiologics.com\/ja\/wp-json\/wp\/v2\/media\/7076"}],"wp:attachment":[{"href":"https:\/\/chimebiologics.com\/ja\/wp-json\/wp\/v2\/media?parent=7074"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/chimebiologics.com\/ja\/wp-json\/wp\/v2\/categories?post=7074"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/chimebiologics.com\/ja\/wp-json\/wp\/v2\/tags?post=7074"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}